1Arterburn, LM, Hall, EB & Oken, H (2006) Distribution, interconversion, and dose response of n-3 fatty acids in humans. Am J Clin Nutr 83, 1467S–1476S.
2Semba, RD (2007) Essential fatty acids and visual development in infants. In Handbook of Nutrition and Ophthalmology, pp. 415–441 [Semba, RD, editor]. New Jersey: Humana Press.
3Le, HD, Meisel, JA, de Meijer, VE, et al. (2009) The essentiality of arachidonic acid and docosahexaenoic acid. Prostaglandins Leukot Essent Fatty Acids 81, 165–170.
4Davis-Bruno, K & Tassinari, MS (2011) Essential fatty acid supplementation of DHA and ARA and effects on neurodevelopment across animal species: a review of the literature. Birth Defects Res (Part B) 92, 240–250.
5Saste, MD, Carver, JD, Stockard, JE, et al. (1998) Maternal diet fatty acid composition affects neurodevelopment in rat pups. J Nutr 128, 740–743.
6Maekawa, M, Takashima, N, Matsumata, M, et al. (2009) Arachidonic acid drives postnatal neurogenesis and elicits a beneficial effect on prepulse inhibition, a biological trait of psychiatric illnesses. PLoS One 4, e5085.
7Uauy, R, Hoffman, DR, Peirano, P, et al. (2001) Essential fatty acids in visual and brain development. Lipids 36, 885–895.
8Age-Related Eye Disease Study Research Group (2007) The relationship of dietary lipid intake and age-related macular degeneration in a case–control study. Arch Ophthalmol 125, 671–679.
9Hartong, DT, Berson, EL & Dryja, TP (2006) Retinitis pigmentosa. Lancet 368, 1795–1809.
10Shintani, K, Shechtman, DL & Gurwood, AS (2009) Review and update: current treatment trends for patients with retinitis pigmentosa. Optometry 80, 384–401.
12Ferrari, S, Di Iorio, E, Barbaro, V, et al. (2011) Retinitis pigmentosa: genes and disease mechanisms. Curr Genomics 12, 238–249.
13Williams, DS (2008) Usher syndrome; animal models, retinal function of Usher proteins, and prospects for gene therapy. Vision Res 48, 433–441.
14Rivas, MA & Vecino, E (2009) Animal models and different therapies for treatment of retinitis pigmentosa. Histol Histopathol 24, 1295–1322.
15Sancho-Pelluz, J, Arango-Gonzalez, B, Kustermann, S, et al. (2008) Photoreceptor cell death mechanisms in inherited retinal degeneration. Mol Neurobiol 38, 253–269.
16Tsubura, A, Yoshizawa, K, Kuwata, M, et al. (2010) Animal models for retinitis pigmentosa induced by MNU; disease progression, mechanisms and therapeutic trials. Histol Histopathol 25, 933–944.
17Yoshizawa, K & Tsubura, A (2005) Characteristics of N-methyl-N-nitrosourea-induced retinal degeneration in animals and application for the therapy of human retinitis pigmentosa. Nippon Ganka Gakkai Zasshi 109, 327–337.
18Yoshizawa, K, Nambu, H, Yang, J, et al. (1999) Mechanisms of photoreceptor cell apoptosis induced by N-methyl-N-nitrosourea in Sprague–Dawley rats. Lab Invest 79, 1359–1367.
19Yoshizawa, K, Kuwata, M, Kawanaka, A, et al. (2009) N-Methyl-N-nitrosourea induced retinal degeneration in mice is independent of the p53 gene. Mol Vis 15, 2919–2925.
20Hussein, N, Fedorova, I, Moriguchi, T, et al. (2009) Artificial rearing of infant mice leads to n-3 fatty acid deficiency in cardiac, neural and peripheral tissues. Lipids 44, 685–702.
21Harauma, A & Moriguchi, T (2011) Dietary n-3 fatty acid deficiency in mice enhances anxiety induced by chronic mild stress. Lipids 46, 409–416.
22Masood, A, Stark, KD & Salem, N Jr (2005) A simplified and efficient method for the analysis of fatty acid methyl esters suitable for large clinical studies. J Lipid Res 46, 2299–2305.
23Yoshizawa, K, Sasaki, T, Uehara, N, et al. (2011) N-Ethyl-N-nitrosourea induces retinal photoreceptor damage in adult rats. J Toxicol Pathol 25, 27–35.
24Hoffman, DR, Boettcher, JA & Diersen-Schade, DA (2009) Toward optimizing vision and cognition in term infants by dietary docosahexaenoic and arachidonic acid supplementation: a review of randomized controlled trials. Prostaglandins Leukot Essent Fatty Acids 81, 151–158.
25Neuringer, M (1993) The relationship of fatty acid composition to function in the retina and visual system. In Lipids, Learning, and the Brain: Fats in Infant Formulas, Report of the 103rd Ross Conference on Pediatric Research, pp. 134–163 [Dobbing, J, editor]. Columbus, OH: Ross Laboratories.
26Suh, M, Wierzbicki, AA, Lien, EL, et al. (2000) Dietary 20 : 4n-6 and 22 : 6n-3 modulates the profile of long- and very-long-chain fatty acids, rhodopsin content, and kinetics in developing photoreceptor cells. Pediatr Res 48, 524–530.
27Anderson, RE, Maude, MB, McClellan, M, et al. (2002) Low docosahexaenoic acid levels in rod outer segments of rats with P23H and S334ter rhodopsin mutations. Mol Vis 8, 351–358.
28Scott, BL, Racz, E, Lolley, RN, et al. (1988) Developing rod photoreceptors from normal and mutant rd mouse retinas: altered fatty acid composition early in development of the mutant. J Neurosci Res 20, 202–211.
29Bazan, NG, Scott, BL, Reddy, TS, et al. (1986) Decreased content of docosahexaenoate and arachidonate in plasma phospholipids in Usher's syndrome. Biochem Biophys Res Commun 141, 600–604.
30Auestad, N, Scott, DT, Janowsky, JS, et al. (2003) Visual, cognitive, and language assessments at 39 months: a follow-up study of children fed formulas containing long-chain polyunsaturated fatty acids to 1 year of age. Pediatrics 112, e177–e183.
31Birch, EE, Castaneda, YS, Wheaton, DH, et al. (2005) Visual maturation of term infants fed long-chain polyunsaturated fatty acid-supplemented or control formula for 12 mo. Am J Clin Nutr 81, 871–879.
32Moriguchi, K, Yuri, T, Yoshizawa, K, et al. (2003) Dietary docosahexaenoic acid protects against N-methyl-N-nitrosourea-induced retinal degeneration in rats. Exp Eye Res 77, 167–173.
33Tsubura, A, Yuri, T, Yoshizawa, K, et al. (2009) Role of fatty acids in malignancy and visual impairment: epidemiological evidence and experimental studies. Histol Histopathol 24, 223–234.
34Moriguchi, K, Yoshizawa, K, Shikata, N, et al. (2004) Suppression of N-methyl-N-nitrosourea-induced photoreceptor apoptosis in rats by docosahexaenoic acid. Ophthalmic Res 36, 98–105.
35Politi, L, Rotstein, N & Carri, N (2001) Effects of docosahexaenoic acid on retinal development: cellular and molecular aspects. Lipids 36, 927–935.
36Rotstein, NP, Aveldano, MI, Barrantes, FJ, et al. (1996) Docosahexaenoic acid is required for the survival of rat retinal photoreceptors in vitro. J Neurochem 66, 1851–1859.
37Katsuki, H & Okuda, S (1995) Arachidonic acid as a neurotoxic and neurotrophic substance. Prog Neurobiol 46, 607–636.
38Kim, HY, Akbar, M & Kim, KY (2001) Inhibition of neuronal apoptosis by polyunsaturated fatty acid. J Mol Neurosci 16, 223–278.
39Kusumoto, A, Ishikura, Y, Kawashima, H, et al. (2007) Effects of arachidonate-enriched triacylglycerol supplementation on serum fatty acids and platelet aggregation in healthy male subjects with a fish diet. Br J Nutr 98, 626–635.
40Nelson, GJ, Schmidt, PC, Bartolini, G, et al. (1997) The effect of dietary arachidonic acid on platelet function, platelet fatty acid composition, and blood coagulation in humans. Lipids 32, 421–425.
42Lien, VW & Clandinin, MT (2009) Dietary assessment of arachidonic acid and docosahexaenoic acid intake in 4–7 year-old children. J Am Coll Nutr 28, 7–15.
43Anonymous (1993) Final report on the safety assessment of arachidonic acid. J Am Coll Toxicol 12, 481–559.
44Maekawa, M, Iwayama, Y, Watanabe, A, et al. (2010) Excessive ingestion of long-chain polyunsaturated fatty acids during developmental stage causes strain- and sex-dependent eye abnormalities in mice. Biochem Biophys Res Commun 402, 431–437.
45Smith, RS & Sundberg, JP (2002) Strain background disease characteristics. In Systematic Evaluation of the Mouse Eye: Anatomy, Pathology, and Biomethods, pp. 67–75 [Smith, RS, editor]. Boca Raton, FL: CRC Press.